Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: FTSE 100 called higher as oil prices firm overnight

22nd Nov 2022 07:54

(Alliance News) - Stocks in London were called slightly higher on Tuesday, as a rising Brent oil price supported the FTSE 100 index, despite unease over Covid-related developments in China. Read More

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

15th Nov 2022 09:58

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

GSK to restrict US use of cancer drug Zejula to some populations

11th Nov 2022 10:44

(Alliance News) - GSK PLC on Friday said it will restrict the use of its niraparib, sold under the brand name Zejula, to patients in the US. Read More

LONDON MARKET CLOSE: Cooling US inflation triggers risk-on rally

10th Nov 2022 17:01

(Alliance News) - Equities in Europe were celebrating a cooler-than-expected US CPI print on Thursday, which gave rise to hopes that peak inflation in the US has passed. Read More

UK dividends calendar - next 7 days

10th Nov 2022 15:54

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

8th Nov 2022 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

LONDON MARKET CLOSE: FTSE 100 lags behind European counterparts

7th Nov 2022 16:57

(Alliance News) - Stock prices in London came to a mixed closed on Monday, as the FTSE 100 underperformed its European peers, while the domestically-focused FTSE 250 index saw a stronger day. Read More

LONDON MARKET MIDDAY: FTSE 100 treads water but European shares rise

7th Nov 2022 12:18

(Alliance News) - The FTSE 100 stood out on Monday, but for the wrong reason, as share price falls for some of its largest constituents meant the index London large-caps underperformed versus the mid-cap FTSE 250 and European indices. Read More

GSK looks to combination trials as cancer drug fails to meet endpoint

7th Nov 2022 08:59

(Alliance News) - GSK PLC on Monday said that its blood cancer drug, Blenrep, has failed to meet its primary endpoint of progression-free survival in recent phase three trials. Read More

TOP NEWS: AstraZeneca's Beyfortus wins EU approval for RSV in newborns

4th Nov 2022 08:08

(Alliance News) - AstraZeneca PLC on Friday said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with Sanofi SA, has received EU approval for prevention of the virus in newborns and infants. Read More

GSK halts enrolment early for UTI trials; moves to regulatory approval

3rd Nov 2022 09:13

(Alliance News) - GSK PLC on Thursday said it was stopping enrolment for its gepotidacin antibiotic trial early, following a recommendation by the Independent Data Monitoring Committee. Read More

LONDON MARKET MIDDAY: Stocks down but Next and GSK bring some cheer

2nd Nov 2022 12:11

(Alliance News) - Stock prices in London edged into the red at midday on Wednesday, as the market awaited a key US interest rate decision, but welcomed positive business updates from GSK and Next. Read More

TOP NEWS: GSK ups annual guidance on "excellent" quarterly performance

2nd Nov 2022 09:26

(Alliance News) - GSK PLC on Wednesday raised its 2022 guidance and said its respiratory syncytial virus older adult vaccine candidate has been granted priority review by the US Food & Drug Administration. Read More

LONDON MARKET OPEN: Aston Martin downgrades outlook; warns on costs

2nd Nov 2022 09:01

(Alliance News) - Trading was timid in London at the market open on Wednesday, after a series of mixed corporate updates, as investors awaited the all-important interest rate decision from the US Federal Reserve, due after the European close. Read More

LONDON BRIEFING: Stocks to edge up ahead of Fed; GSK raises guidance

2nd Nov 2022 07:49

(Alliance News) - Stock prices in London were called slightly higher on Wednesday, as investors awaited the all-important interest rate decision to come from the US Federal Reserve. Read More

Haleon announces results for exchange offers from GSK spin-off

31st Oct 2022 14:28

(Alliance News) - Haleon PLC on Monday announced the pricing for offers to exchange six series of outstanding unregistered notes issued by GSK Consumer Healthcare Capital US LLC and one series by GSK Consumer Healthcare Capital UK PLC due between 2024 and 2052, which Haleon announced on September 29. Read More

LONDON MARKET CLOSE: Eyes on BoE decision; NatWest drags down FTSE 100

28th Oct 2022 17:05

(Alliance News) - Stocks in London closed in the red on Friday, but clung on for week gains, as interest rate decisions from the Bank of England and the US Federal Reserve move into focus. Read More

TOP NEWS: GSK gets support from European panel for HIV prevention

28th Oct 2022 08:44

(Alliance News) - GSK PLC on Friday said its majority owned ViiV Healthcare venture has received the European Medicines Agency's validation for its marketing authorisation application for HIV prevention, and said its MAA for respiratory syncytial virus adult vaccine has also been accepted. Read More

US FDA advisory panel votes against GSK kidney drug use in some cases

27th Oct 2022 10:02

(Alliance News) - GSK PLC on Thursday said a US Food & Drug Administration panel has supported daprodustat for adults on dialysis but not for non-dialysis adults, and provided an update on the ContRAst phase III programme for otilimab. Read More

UK earnings, trading statements calendar - next 7 days

26th Oct 2022 15:53

FTSE 100 Latest

Value8,275.66

Change0.00